Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada.

Authors

Dimas Yusuf

Dimas Yusuf

Cross Cancer Institute, Edmonton, AB, Canada

Dimas Yusuf, Jenny J. Ko, Hyokeun Cho, Corey Sheremeto, Ying Wang, Rosalyn A. Juergens, Peter Michael Ellis, Alkarim Billawala, Amin Kay, Swati Kulkarni, Tarek A. Elfiki, Rasna Gupta, Krista Naccarato, Alex Pennetti, Devalben Patel, Elliot Charles Smith, Ryan Walton, Manjusha Hurry, Geoffrey Liu, Winson Y. Cheung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr 54)

Abstract #

54

Poster Bd #

C3

Abstract Disclosures